These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21555871)

  • 1. The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease.
    Opstad TB; Pettersen AA; Bratseth V; Arnesen H; Seljeflot I
    Pathophysiol Haemost Thromb; 2010; 37(2-4):98-103. PubMed ID: 21555871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis.
    Lindström OK; Tukiainen EM; Kylänpää ML; Mentula PJ; Puolakkainen PA; Wartiovaara-Kautto UM; Repo H; Petäjä JM
    Pancreatology; 2011; 11(6):557-66. PubMed ID: 22213026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor.
    Bartok A; Steiner S; Seidinger D; Jetzl A; Huber K; Minar E; Stefenelli T; Kopp CW
    Thromb Res; 2005; 115(6):469-74. PubMed ID: 15792677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Nov; 102(5):945-50. PubMed ID: 19888533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation.
    Adams M; Breckler L; Stevens P; Thom J; Baker R; Oostryck R
    Haematologica; 2004 Aug; 89(8):985-90. PubMed ID: 15339683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of TF and TFPI activities in patients with hypertension or coronary atherosclerotic heart disease].
    Xiao Z; Wang W; Han J; He X; Li J
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):251-2, 255. PubMed ID: 12016797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
    J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
    Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M
    Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
    Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
    Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of LDL-associated tissue factor pathway inhibitor.
    Augustsson C; Hilden I; Petersen LC
    Thromb Res; 2014 Jul; 134(1):132-7. PubMed ID: 24787991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
    Lupu C; Kruithof EK; Kakkar VV; Lupu F
    Thromb Haemost; 1999 Dec; 82(6):1652-8. PubMed ID: 10613651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor and tissue factor pathway inhibitors TFPI and TFPI2 in human secretory endometrium--possible link to female infertility.
    Altmäe S; Salumets A; Bjuresten K; Kallak TK; Wånggren K; Landgren BM; Hovatta O; Stavreus-Evers A
    Reprod Sci; 2011 Jul; 18(7):666-78. PubMed ID: 21421890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric patients with congenital heart disease: thrombin generation measured by calibrated automated thrombography.
    Rosenkranz A; Koestenberger M; Novak M; Cvirn G; Leschnik B; Gamillscheg A; Beitzke A; Muntean W
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):389-93. PubMed ID: 18600087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease.
    Koestenberger M; Cvirn G; Nagel B; Rosenkranz A; Leschnik B; Gamillscheg A; Beitzke A; Muntean W
    Thromb Res; 2008; 122(1):13-9. PubMed ID: 17915295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.